239 related articles for article (PubMed ID: 25431893)
1. Pharmacogenetics of drug-metabolizing enzymes in US Hispanics.
Claudio-Campos K; Duconge J; Cadilla CL; Ruaño G
Drug Metab Pers Ther; 2015 Jun; 30(2):87-105. PubMed ID: 25431893
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
Serpe L; Canaparo R; Scordo MG; Spina E
Drug Metab Pers Ther; 2015 Jun; 30(2):107-20. PubMed ID: 25527811
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
Bosch TM; Doodeman VD; Smits PH; Meijerman I; Schellens JH; Beijnen JH
Mol Diagn Ther; 2006; 10(3):175-85. PubMed ID: 16771603
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
Bosch TM; Meijerman I; Beijnen JH; Schellens JH
Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 Drug Metabolizing Enzymes in Roma Population Samples: Systematic Review of the Literature.
Szalai R; Hadzsiev K; Melegh B
Curr Med Chem; 2016; 23(31):3632-3652. PubMed ID: 27516201
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
Pratt VM; Everts RE; Aggarwal P; Beyer BN; Broeckel U; Epstein-Baak R; Hujsak P; Kornreich R; Liao J; Lorier R; Scott SA; Smith CH; Toji LH; Turner A; Kalman LV
J Mol Diagn; 2016 Jan; 18(1):109-23. PubMed ID: 26621101
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of drug metabolizing enzymes in the United Kingdom population: review of current knowledge and comparison with selected European populations.
Daly AK
Drug Metab Pers Ther; 2015 Sep; 30(3):165-74. PubMed ID: 25803091
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of healthy volunteers in Puerto Rico.
Claudio-Campos K; Orengo-Mercado C; Renta JY; Peguero M; García R; Hernández G; Corey S; Cadilla CL; Duconge J
Drug Metab Pers Ther; 2015 Dec; 30(4):239-49. PubMed ID: 26501165
[TBL] [Abstract][Full Text] [Related]
9. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
11. Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes.
Makeeva O; Stepanov V; Puzyrev V; Goldstein DB; Grossman I
Pharmacogenomics; 2008 Jul; 9(7):847-68. PubMed ID: 18597650
[TBL] [Abstract][Full Text] [Related]
12. Brief review of polymorphic drug-metabolizing enzymes in Japanese populations: development of a higher-throughput genotyping method and proposed applications.
Kubota T
Drug Metab Lett; 2007 Apr; 1(2):137-42. PubMed ID: 19356033
[TBL] [Abstract][Full Text] [Related]
13. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
Nebert DW; McKinnon RA; Puga A
DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
Kirchheiner J; Seeringer A
Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
[TBL] [Abstract][Full Text] [Related]
15. Identifying drugs needing pharmacogenetic monitoring in a Korean hospital.
Kim YM; Yoo SH; Kang RY; Kim MJ; Bae YY; Lee YK; Jeon SJ; Chon KJ; Shin SM; Kim SG; Park KH; Son IJ
Am J Health Syst Pharm; 2007 Jan; 64(2):166-75. PubMed ID: 17215467
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics approach to therapeutics.
Koo SH; Lee EJ
Clin Exp Pharmacol Physiol; 2006; 33(5-6):525-32. PubMed ID: 16700889
[TBL] [Abstract][Full Text] [Related]
17. How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.
Meisel C; Roots I; Cascorbi I; Brinkmann U; Brockmöller J
Clin Chem Lab Med; 2000 Sep; 38(9):869-76. PubMed ID: 11097342
[TBL] [Abstract][Full Text] [Related]
18. Phase I and Phase II enzyme polymorphisms and childhood cancer.
Swinney R; Hsu S; Tomlinson G
J Investig Med; 2006 Sep; 54(6):303-20. PubMed ID: 17134614
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.
Ashton LJ; Murray JE; Haber M; Marshall GM; Ashley DM; Norris MD
Pharmacogenet Genomics; 2007 Sep; 17(9):709-17. PubMed ID: 17700360
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: the CEIBA cocktail.
de Andrés F; Sosa-Macías M; Lazalde-Ramos BP; Naranjo ME; Tarazona-Santos E; Llerena A;
Drug Metabol Drug Interact; 2013; 28(3):135-46. PubMed ID: 23787463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
